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Efficient detection of delirium and comorbid delirium-dementia is a key
diagnostic challenge. Development of new, efficient delirium-focused methods of
cognitive assessment is a key challenge for improved detection of neurocognitive
disorders in everyday clinical practice.
AIM
To compare the accuracy of two novel bedside tests of attention, vigilance and
visuospatial function with conventional bedside cognitive tests in identifying
delirium in older hospitalized patients.
METHODS
180 consecutive elderly medical inpatients (mean age 79.6 ± 7.2; 51% female)
referred to a psychiatry for later life consultation-liaison service with delirium,
dementia, comorbid delirium–dementia and cognitively intact controls.
Participants were assessed cross-sectionally with conventional bedside cognitive
tests [WORLD, Months Backward test (MBT), Spatial span, Vigilance A and B,
Clock Drawing test and Interlocking Pentagons test] and two novel cognitive
tests [Lighthouse test, Letter and Shape Drawing test (LSD)-4].
RESULTS
Neurocognitive diagnoses were delirium (n = 44), dementia (n = 30), comorbid
delirium-dementia (n = 60) and no neurocognitive disorder (n = 46). All
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conventional tests had sensitivity of > 70% for delirium, with best overall
accuracy for the Vigilance-B (78.3%), Vigilance-A (77.8%) and MBT (76.7%) tests.
The sustained attention component of the Lighthouse test was the most
distinguishing of delirium (sensitivity 84.6%; overall accuracy 75.6%). The LSD-4
had sensitivity of 74.0% and overall accuracy 74.4% for delirium identification.
Combining tests allowed for enhanced sensitivity (> 90%) and overall accuracy (≥
75%) with the highest overall accuracy for the combination of MBT-Vigilance A
and the combined Vigilance A and B tests (both 78.3%). When analyses were
repeated for those with dementia, there were similar findings with the MBT-
Vigilance A the most accurate overall combination (80.0%). Combining the
Lighthouse-SA with the LSD-4, a fail in either test had sensitivity for delirium of
91.4 with overall accuracy of 74.4%.
CONCLUSION
Bedside tests of attention, vigilance and visuospatial ability can help to
distinguish neurocognitive disorders, including delirium, from other
presentations. The Lighthouse test and the LSD-4 are novel tests with high
accuracy for detecting delirium.
Key words: Visuospatial function; Attention; Vigilance; Letter and Shape Drawing test;
Lighthouse test; Delirium; Dementia; Phenomenology; Assessment
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: This study examines the accuracy of a range of conventional and novel bedside
cognitive tests in identifying delirium amongst older medical patients within a general
hospital setting. The novel tests (Letter and Shape Drawing test, and Lighthouse test)
compare favourably with conventional tests and may be particularly useful by virtue of
their capacity to provide highly consistent testing in real world practice.
Citation: Meagher DJ, O’Connell H, Leonard M, Williams O, Awan F, Exton C, Tenorio M,
O’Connor M, Dunne CP, Cullen W, McFarland J, Adamis D. Comparison of novel tools with





Major  neurocognitive  disorders  are  linked  to  a  variety  of  adverse  outcomes  in
hospitalized elderly[1,2].  However, these disorders are under-detected in everyday
practice, leading to avoidable morbidity and mortality, rendering more accurate and
timely  recognition  a  key  healthcare  target[3,4].  A  major  obstacle  to  improved
management of neurocognitive difficulties is the lack of clarity regarding optimal
approaches to bedside cognitive assessment[5].
Recent studies exploring the phenomenological profile of major neurocognitive
disorders suggest that tests of attention, vigilance and visuospatial abilities have
particular utility in distinguishing neurocognitive disorders because these domains
are disproportionately affected in delirium[6-10]. The results of such studies have the
potential to lead to identification of a “cognitive vital sign” for routine and systematic
assessment of cognition at the bedside in everyday practice.
Traditional or conventional bedside tests of cognition can assist  in identifying
delirium-relevant cognitive disturbances. However, these tests were developed in the
last  century  and  predate  the  modern  concept  of  delirium that  has  been  widely
accepted since Diagnostic and Statistical Manual of Mental Disorders (DSM)-III in
1980[11]. Among their limitations for assessing for delirium are that they are subject to
“bottoming-out” effects because they are too difficult for many patients, who cannot
meaningfully engage with testing procedures[12]. Moreover, although these tests are
widely used, there is major disparity in how they are administered and interpreted.
For  example,  Meagher  et  al[13]  found marked inconsistency in  use of  the Months
Backward test (MBT) with almost no evidence of similar scoring of test performance
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across 22 clinical studies. Similarly, a review of 16 studies of the Clock Drawing Test
(CDT)  in  delirium  identified  11  different  scoring  methods[14].  As  such,  more
systematized and reliable methods of cognitive testing are needed, either based upon
existing tests or by developing novel approaches to testing that draw upon modern
(e.g., computer-assisted/smartphone) technologies.
To  this  end,  the  Cognitive  Impairment  Research  Group  at  the  University  of
Limerick developed two novel tests specifically for the purpose of detecting cognitive
difficulties  that  characterize  delirium:  The  Lighthouse  test,  which  focuses  on
attention/vigilance and the Letter and Shape Drawing test (LSD-4), which focuses
upon visuospatial abilities[15-17]. This study the accuracy of a series of commonly used
conventional tests as well as these novel tests in the detection of delirium in a real
world sample of older hospital medical patients. Specifically, the aims were to (1)
compare  performance  on these  different  tests  in  identifying delirium in  elderly
inpatients with varying neurocognitive disorder profiles as well as those with normal
cognition; (2) examine how they compare (both individually and in combination) in
terms  of  their  specificity,  sensitivity,  positive  and  negative  predictive  value  in
detecting delirium and comorbid delirium-dementia in older medical inpatients; and
(3) explore how accuracy is impacted upon by comorbid dementia.
MATERIALS AND METHODS
Subjects and design
A cross-sectional study of cognitive performance was conducted in referrals to a
consultation-liaison psychiatry service of patients with delirium, dementia, comorbid
delirium-dementia, as well as comparison subjects with no neurocognitive diagnosis
(NNCD). Consecutive cases with altered mental state were identified on daily rounds
by the medical team and referred for assessment and diagnosis by the research team.
Assessments  were  conducted  by  raters  (Leonard  M,  Awan  F,  O’Connell  H,
Williams O, Meagher DJ) specifically trained in the use of the tests included herein
(see below) and to further enhance inter-rater reliability, ratings associated with any
uncertainty were discussed and agreed by consensus between raters.
Patients were assessed during the usual working day and in the majority of cases
the process of receiving referrals and responding meant that this occurred in the early
afternoon  when the  anchors  of  the  day  are  thought  to  be  optimally  active.  The
assessments were conducted at the bedside to mimic real world practice.
Delirium was diagnosed according to a cut-off score of ≥ 15 on the severity scale of
the  Delirium Rating  Scale-Revised-98  (DRS-R98)[18]  and/or  presence  of  DSM IV
criteria[19] based upon a full clinical assessment. This approach was used because it
allows for high diagnostic specificity in populations that include substantial numbers
of  patients  with comorbid dementia.  Dementia was defined as a  clear history of
documented DSM-IV[19] dementia (based on all available information at the time of
assessment including clinical case notes and collateral history from family and/or
carers)  or  a  short  Informant  Questionnaire  on  Cognitive  Decline  in  the  elderly
(IQCODE) score of ≥ 3.5[20]. Comorbid delirium-dementia was defined as the presence
of both disorders.
Each subject was assessed with a battery of nine conventional (Rater A) and 2 novel
(Rater B) tests (see below). Standard cut off performances were used to apply a binary
(pass/fail)  for  each  test  where  a  fail  corresponded  with  evidence  of  clinically
significant  impairment.  Assessors  were  not  aware  of  the  patients’  formal
neurocognitive diagnoses. The cognitive tests were conducted in a fixed sequence as
described below.
Informed consent
The procedures and rationale for the study were explained to all patients but because
many patients had cognitive impairment at entry into the study it was presumed that
many might not be capable of giving informed written consent. Because of the non-
invasive nature of the study, University Hospital Limerick Regional Ethics Committee
approved (REC 100/12) an approach to establishing consent by virtue of augmenting
patient assent with proxy consent from next of kin (where possible) or a responsible
caregiver for all participants in accordance with the Helsinki Guidelines for Medical
Research involving human subjects[21].
Assessments
Demographic data and medication at the time of the assessment were recorded. All
available information from medical records and collateral history was used. Nursing
staff were interviewed to assist rating of symptoms over the previous 24 h.
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The DRS-R98[18] is designed for broad phenomenological assessment of delirium. It
is  a  16-item  scale  with  13  severity  and  3  diagnostic  items  with  high  interrater
reliability, sensitivity and specificity for detecting delirium in mixed neuropsychiatric
and other hospital populations. Each item is rated 0 (absent/normal) to 3 (severe
impairment) with descriptions anchoring each severity level. Severity scale scores
range  from  0-39  with  higher  scores  indicating  more  severe  delirium.  Delirium
typically involves scores above 15 points (Severity scale) or 18 points (Total scale)
when dementia is in the differential diagnosis.
The IQCODE-SF is a validated screening tool for detecting cognitive impairment.
The short version of the IQCODE includes 16 items that rate cognitive change over
time, each of which are rated by an informant on a 5 point Likert scale. The total score
divided by the number of questions provides a mean item score where ratings ≥ 3.5
are considered indicative of longstanding cognitive difficulties and dementia[20].
Cognitive testing
WORLD backwards:  The WORLD backwards test  was applied according to  the
Mini–Mental  State  Examination[22].  Each participant  was  asked to  spell  WORLD
backwards. Patients who self-corrected their own mistakes without prompting when
spelling WORLD backwards were not penalized. Failure to correctly recite all five
letters is considered to equate with clinically significant inattention (and thus a failed
test).
MBT: In this test, the participant was asked to recite the months of the year in reverse
order starting from December. Test duration was a maximum of 90 seconds at which
point the subject’s best performance was noted. Scoring in subjects over age 60 is that
failure to reach July without more than one error of omission equates with clinically
significant inattention (and thus a failed test)[13].
Spatial  span forwards:  This  was  conducted  according  to  the  description  in  the
Cognitive test for delirium (CTD)[23]. The Spatial span forwards is a visual form of the
digit span forwards. The subject is asked to copy the examiner in touching squares on
a card (A5 size with 8 cm × 1 cm red squares). Each square represents a number and
the test on each occasion requires that the squares corresponding to the digit span
code  are  tapped at  one  second intervals.  Two trials  are  conducted and the  best
performance is used. Failure to correctly complete a sequence of 5 or more numbers is
considered to equate with clinically significant inattention (and thus a failed test).
Spatial span backwards: Similarly, the Spatial span backwards uses squares (blue)
that are repeated in reverse order to that indicated by the assessor. Two trials are
conducted and the best performance is used. Failure to correctly complete a sequence
of three or more numbers is considered to equate with clinically significant inattention
(and thus a failed test).This was also conducted according to the description in the
original description of the CTD[23].
Vigilance A test: The vigilance “A” test was also derived from the CTD scale[23]. A list
of 29 letters with the letter “A” included on 11 occasions was presented to the patient
and they were asked to indicate each time the letter “A” was mentioned. Scores are
calculated by subtracting commissions from correct responses (scored double) and
rated as unable to engage with the test (0), score 1-9 (1), score 10-18 (2), score 19-26 (3),
score > 27 (4). For the purposes of a binary (pass/fail) cutoff, we used failure to score
> 27 to equate with significantly impaired vigilant (or sustained) attention.
Vigilance B test:  This is  similar to the vigilance A test  except that there are two
required letters (“C” and “E”). Scores are calculated by subtracting commissions from
correct responses (scored double) and rated as unable to engage with the test (0), score
1-9 (1), score 10-18 (2), score 19-26 (3), score > 27 (4). For the purposes of a binary
(pass/fail) cutoff, we used failure to score ≥ 19 to equate with significantly impaired
vigilant (or sustained) attention[23].
Global assessment of visuospatial abilities: Visuospatial ability was rated according
to a four point scale based upon DRS-R98 item 13[24] using both patient and collateral
sources regarding ability to perceive differences in shape and distance as well as
practical abilities such as navigating the ward environment and response to specific
probes of  describing how to get  somewhere (e.g.,  bathroom),  recognising shapes
(“what shape is the window?”) and differences in distances (“which is closer the window or
the hallway?”). Patients with moderate or greater impairment in terms of responses to
probes  and/or  reported  need  for  redirection  to  keep  from  getting  lost  in  the
environment or difficulty locating familiar objects in immediate environment were
considered to have pathological impairment of visuospatial abilities (failed test).
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Intersecting Pentagons test: This geometric copying test is derived from the original
Bender  Gestalt  test[25].The  subject  is  presented  with  a  copy  of  two  intersecting
pentagons drawn at angles to one another producing a diamond shape where they
overlap. The subject is requested to copy the design on the blank half of the page. For
scoring,  we applied the six-point hierarchical  scoring scale where 6 represents a
perfect reproduction and 1 represents the poorest effort with scores < 4 equated with
a failed performance[26].
CDT:  The  CDT  examines  visuospatial  abilities  as  well  as  receptive  language,
numerical knowledge, working memory, and executive functions. It is widely used in
geriatric practice as a cognitive scan. In this study, subjects were provided with a pre-
drawn circle onto which the participant was requested to place all the numbers and
the large and small hands on the clock face to show the time “ten past eleven”. We
used the scoring method of Sunderland et al[27] (1989) rating performance from 0 to 10
according to spatial representation of the numbers and hands of the clock. A score of
< 6 equates with a failed performance.
LSD: The LSD is a novel test designed to emphasize visuospatial abilities[15]. It consists
of a series of 4 designs that link 1cm spheres arranged in increasingly complex grids
that the subject copies to an adjacent blank grid. The complexity ranges from very
simple (copying an “X” on a 3 by 3 grid which is thought to assess awareness and
basic understanding of the test procedures as well as physical ability to engage with
testing) to increasingly more complex figures (e.g.,  on a 6 by 6 grid) designed to
challenge  those  with  higher  levels  of  cognitive  ability  (Figure  1).  A  correct
performance requires that all relevant spheres are connected to complete the required
shape. Omissions (but not commissions) are rated as errors. Subjects are permitted a
single trial of each of the 4 items. Each item is scored 0 or 1 depending on whether all
target zones on the grid are completed, allowing for a total score ranging from 0-4.
Scores  less  than  3  are  considered  to  reflect  clinically  significant  impairment  of
performance and equate with a failed performance[17].The test typically takes 1-2 min
to complete. The test can be presented either as pen and paper or digitalised formats.
The latter can allow for delivery of a more versatile test (that can be readily adapted to
individual characteristics such as impaired visual or motor skills)[16]. The LSD thus
provides a brief and easily interpreted bedside test of visuospatial function.
The  Lighthouse  test:  The  Lighthouse  test  was  developed  by  the  Cognitive
Impairment Research Group as an objective assessment of awareness, focused and
sustained attention. It is administered using an Android smartphone and involves
presentation  of  an  image  of  a  flashing  lighthouse  on  a  standard  screen  (3”  ×
5”)(Figure  2).  The  test  has  3  main  sections;  (1)  assessing  whether  the  subject
recognizes  the  lighthouse  as  such;  (2)  assessing  the  subject’s  capacity  to  focus
attention to describe the number of times the lighthouse flashes (×3 sequences; 4, 3, 5).
Subjects are requested to identify the number of flashes; and (3) testing the capacity to
sustain attention to count sequences of flashes (×3) (i.e. 4-3-2, 3-2-5, 2-4-3) that last 12-
15 seconds in duration. Again, subjects are requested to identify the total number of
flashes.
Statistical analyses
Statistical analysis was conducted using SPSS-19[28]. Continuous data are presenting as
means  plus  standard  deviation.  Categorical  data  are  presented  as  counts  and
percentages. When multiple comparisons were conducted (ANOVA) the Bonferroni
correction for multiple comparisons was used. The accuracy of tests of cognition (and
their  combinations),  sensitivity  and specificity  as  well  as  positive  and negative
likelihood ratio,  Positive  Predictive  Value,  and Negative  Predictive  Value  were
calculated, with confidence intervals testing significance at 95%. Post hoc power
calculation for the main research question (the ability of LSD-4 to detect delirium
against no delirium) was performed by using the G*Power v3.1.2. software. With a =
0.05, effect size = 0.5 and df = 3, a sample size of 180 indicated power of almost 1
(0.99).
RESULTS
A total of 180 patients were assessed [mean age 79.6 ± 7.2;  91 (51%) female].  The
frequencies of neurocognitive diagnoses were; delirium (n = 44), dementia (n = 30),
comorbid delirium-dementia (n = 60) and NNCD (n = 46). Demographic, medication
and general clinical data for these four groups are shown in Table 1. There were no
significant differences between the four groups in respect of age, gender distribution
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Figure 1
Figure 1  The Letter and Shape Drawing test.
or number of medications received, while psychotropic medication use was higher in
those with any neurocognitive diagnosis.
Table 1 compares mean scores for the four groups for the DRS-R98 and IQ-CODE.
Both delirium groups were more impaired than the dementia and NNCD groups on
total  scores  for  the DRS-R98.  For  the short  IQCODE mean scores  both dementia
groups scored well above the suggested cut-off score and higher than the delirium-
only and NNCD groups.
Table 2 and Table 3 show the performance on the conventional cognitive tests for
the four neurocognitive groups, including accuracy for delirium diagnosis in the
overall group as well as within the group with diagnosed dementia (n = 90) (Figure 3).
Of note, all tests of attention and vigilance had a sensitivity for delirium of > 70% but,
in terms of overall accuracy, the Vigilance A and B and MBT were the best performing
tests. The tests of visuospatial ability were less sensitive to delirium, with the global
assessment of visuospatial abilities (GVS) performing slightly better than the CDT and
Intersecting Pentagons test (IPT).
Tables 4 and 5 show the performance on the three components of the Lighthouse
test  and the LSD-4.  Overall,  only one third of  patients  were  able  to  identify  the
lighthouse  correctly,  with  one  third  unable  to  describe  it  while  the  other  third
described  it  in  a  variety  of  ways  including  as  “a  lampost”,  “a  traffic  light”,  “a
chimney” and “the Eiffel tower”. The identification and focused attention components
of the Lighthouse had substantially lower sensitivity and overall accuracy compared
to the sustained attention (LH-SA) element and when combined with the LH-SA did
not substantially add to its accuracy. The LH-SA alone compared favourably with the
conventional tests of attention. Similarly, the LSD-4 compared favourably with the
conventional tests of visuospatial abilities in terms of sensitivity and overall accuracy
for detecting delirium, especially in those patients with dementia.
We examined the accuracy of various combinations of the conventional tests and
the LH-SA/LSD in detecting delirium in the overall group and in the dementia group.
The better performing combinations (i.e.  those with sensitivity > 90% and overall
accuracy ≥ 75%) are shown in Table 6. For the overall group, the MBT-GVS and the
combined Vigilance A and B tests were the most sensitive combination (93.3%), while
the MBT-Vigilance A and the combined Vigilance A and B tests  had the highest
overall accuracy (78.3%), with the LH-SA/LSD combination demonstrating similar
levels of accuracy. When these analyses were repeated for the population with DSM-
IV defined dementia, there were similar findings with the MBT-Vigilance A the most
accurate overall combination (80.0%), followed by the LH-SA/LSD and combined
Vigilance A and B tests (both 77.8%).
DISCUSSION
Performance on bedside tests of attention and visuospatial ability was compared in
elderly medical inpatients with a variety of neurocognitive diagnoses and also with
normal cognition. Participants were carefully diagnosed using a full neuropsychiatric
assessment with well-validated instruments. Patients with active delirium (both with
and without comorbid dementia) were distinguished from patients with dementia-
alone in respect of performance on simple bedside tests. Moreover, combining tests of
attention with visuospatial ability allowed for greater accuracy of delirium detection.
Two novel cognitive tests, the LSD test both compare favourably with conventional
tests and may offer advantages for use in everyday practice.
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Figure 2
Figure 2  The Lighthouse test.
One  important  implication  of  this  study  is  that  formal  testing  using  any
conventional test can assist delirium detection – all tests were quite sensitive to the
presence of delirium but the Vigilance A and B and the MBT were the best individual
tests in terms of overall accuracy. This is in keeping with previous studies that have
included direct comparisons of cognitive tests in the identification of delirium in
elderly general hospital inpatients and which have consistently found that bedside
tests  of  attention  (including  sustained or  vigilant  attention)  are  sensitive  to  the
presence of delirium, with the Months Backward Test emerging as the most versatile
individual test[10,29-33].
The Lighthouse is a novel test that includes three components designed to assess
awareness/comprehension, focused attention and sustained attention. Somewhat
surprisingly, only one third of subjects could correctly identify the Lighthouse thus,
raising the possibility that the visual graphics are suboptimal. Although the ID and
FA components did not individually add to the accuracy of the Lighthouse test for
delirium, the testing procedures involved engaging with the stimulus and simple
testing and may thus have optimised arousal and attention for the sustained attention
component.
The LSD performed well in terms of delirium detection, demonstrating greater
accuracy than the conventional visuospatial bedside tests (CDT and IPT), especially in
those patients with dementia. Previous work has emphasised visuospatial function as
a cognitive function that, along with attention, is particularly affected in delirium[6-10].
However, other work suggests that conventional tests such as the CDT lack specificity
for  delirium  compared  to  dementia[14,32,34].  In  contrast,  the  LSD  which  has  been
designed with the aim of optimising delirium-relevance, evidenced better specificity
for delirium.
Efforts to identify optimal bedside cognitive testing for delirium monitoring should
recognise that combining two tests that focus upon different aspects of cognition that
are impaired in delirium can enhance accuracy of testing as well as inform delirium
diagnosis which requires evidence of generalised disturbance to brain function. This
should  include  impaired  attention  with  deficits  in  at  least  one  other  cognitive
domain[35]  -  visuospatial functioning offers a suitable second domain. In terms of
accuracy, this work suggests that combining two tests can achieve > 90% sensitivity
with high overall test accuracy. Combining the MBT with the Vigilance-A test is a
particularly useful approach using conventional tests, while the combination of the
LSD-4 with the sustained attention component of the Lighthouse test offers a novel
approach that has similar accuracy. The latter has the advantage of being delivered by
smartphone/tablet  technology  which  can  allow  for  enhanced  consistency  and
reliability in test administration and interpretation. Moreover, digital technology
offers the prospect of developing testing procedures that can be readily adapted
according to individual patient characteristics such as visual acuity, frailty and motor
dexterity – for example by altering the dimensions of presented material and/or the
size of target zones on the LSD-4.
The  LSD-4  and  the  Lighthouse  are  designed  to  emphasize  consistency  of
administration and ease of interpretation. The methods applied in this study allowed
for highly consistent administration procedures and detailed scoring systems that are
not typically applied in everyday practice when using conventional bedside tests.
Recent reviews[13,14] emphasize that conventional tools such as the MBT and the CDT
are subject to considerable variability in use, with a lack of consensus as to optimal
methods  of  administration  and  interpretation.  As  such,  the  accuracy  of  the
conventional tests is likely to be lower in real world use. In contrast, the Lighthouse
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Table 1  Demographic and clinical data for the total group and four neurocognitive groups (mean + SD)
Total group (n = 180) Delirium (n = 44) Comorbid delirium-dementia (n = 60) Dementia (n = 30)
No neurocognitive
disorder (n = 46)
Female (%) 51% 53% 56% 37% 48%
Age 79.6 ± 7.2 77.7 ± 8.4 80.1 ± 7.0 81.8 ± 4.6 79.3 ± 7.5
Total number of
medications
10.1 ± 4.7 10.0 ± 4.2 10.3 ± 5.0 9.7 ± 4.4 10.3 ± 5.1
Number of
psychotropics2
1.7 ± 1.6 1.9 ± 1.6 2.2 ± 1.7 1.7 ± 1.6 0.8 ± 1.1
DRS-R98 total12 17.0 ± 9.2 22.9 ± 5.7 24.0 ± 6.0 10.9 ± 4.4 6.5 ± 3.3
Short IQCODE3 3.7 ± 0.7 3.1 ± 0.1 4.4 ± 0.5 4.0 ± 0.5 3.1 ± 0.1
1Delirium and comorbid delirium-dementia > dementia at P < 0.001.
2Delirium-only, dementia-only and comorbid delirium-dementia groups > no neurocognitive diagnosis (NNCD) at P < 0.001.
3Dementia and comorbid delirium-dementia groups > delirium and NNCD groups at P < 0.001. DRS-R98: Delirium Rating Scale-Revised-98; IQCODE:
Informant Questionnaire on Cognitive Decline in the elderly.
test and the LSD-4 are more likely to maintain the accuracy evident herein due to their
presentation in computerized format which enhances consistency of delivery and
scoring and which may be associated with relatively less reduction in accuracy when
used in everyday practice. In addition, we expect that the Lighthouse and LSD will be
less subject to language-related inaccuracies than many other tests because they do
not emphasize verbal skills.  Future work can examine these issues, including the
relative accuracy of computerized forms.
The combination of simple tests can allow for rapid and efficient assessment of
delirium-relevant cognitive domains and achieved a sensitivity of almost 90% for
delirium presence with these cross-sectional assessment methods. Serial monitoring of
performance on these tests as a “cognitive vital sign” could allow for highly consistent
detection of delirium in real world practice. Moreover, presentation in computerized
formats could make for highly systematized assessment procedures that, given the
modest  specificity  of  55%,  would  ideally  be  enhanced  by  a  second  phase  of
assessment for patients who identify as positive. This two-step approach to delirium
detection is increasingly advocated as an effective means of improving detection rates
in everyday clinical practice[5,36].  It  is  important to note that although identifying
cognitive impairment is central to delirium diagnosis, actual diagnosis requires that
the timing (relatively acute onset) and context (a deterioration from usual baseline,
not better explained by another neuropsychiatric condition and due to a physical
etiology) also be determined. Tools such as the confusion assessment method[37] and
DRS-R98[18] incorporate these additional considerations to allow for formal diagnosis.
Ultimately, systematized cognitive testing is key to delirium screening efforts and can
also be used to support the cognitive assessment that is inherent to formal diagnosis.
Psychometric data to guide the choice of test in particular settings is relatively lacking
but ultimately the choice of cognitive testing tool is determined by a variety of factors
that  relate  to  patient,  tester  and other  resource  issues  that  are  particular  to  the
healthcare environment. Further work exploring the impact of these factors on the
efficiency of providing cognitive-friendly healthcare is needed to guide choice of
testing methods across settings.
Study limitations
This work has some notable shortcomings which include (1) We studied consecutive
referrals to a consultation-liaison service for assessment of neuropsychiatric status. As
such, these patients are likely to have a heightened symptom burden and are not
representative of elderly inpatients in general; (2) We applied binary cut off ratings
for  each of  the  tests  based upon best  convention but  for  many tests  a  clear  and
consistently agreed pass/fail  distinction is lacking; (3) We used a fixed order for
presentation of the tests which may have influenced performance due to changing
levels of arousal during the testing process and with the competing effects of practice
versus fatigue[38]; and (4) We did not specify the stage or primary cause of dementia or
take account of clinical subtypes of delirium (i.e. hypoactive, hyperactive and mixed
motor subtype) although evidence indicates that neurocognitive disturbance varies
across dementia types and severity[39].
Implications
Improved  identification  of  major  neurocognitive  disorders  is  a  key  healthcare
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Table 2  Performance on the Conventional bedside cognitive tests for the overall population and for each of the neurocognitive
diagnostic groups (number completing correctly and %)
Overall group (n =
180) Delirium (n = 44)
Comorbid delirium-dementia (n =
60) Dementia (n = 30) NNCD (n = 46)
World backwards test 42 (23) 6 (14) 5 (8) 6 (20) 25 (54)
Months backwards test 74 (41) 12 (28) 8 (13) 20 (66) 34 (74)
Spatial span forwards 68 (38) 14 (32) 12 (20) 13 (43) 29 (63)
Spatial span backwards 67 (37) 15 (34) 8 (13) 15 (50) 29 (63)
Vigilance A test 88 (49) 16 (36) 10 (17) 23 (77) 39 (85)
Vigilance B test 49 (27) 3 (7) 3 (5) 13 (43) 30 (65)
Global visuospatial test 72 (40) 9 (20) 15 (25) 12 (40) 37 (80)
Clock drawing test 78 (43) 16 (36) 13 (22) 14 (47) 35 (76)
Interlocking pentagons
test
87 (48) 17 (39) 14 (23) 18 (60) 38 (83)
NNCD: No neurocognitive diagnosis.
challenge. In particular, accurate and consistent detection of delirium is a priority
because evidence indicates that more than half of cases are missed or detected late in
everyday practice, with implications for morbidity, length of stay in hospital and
mortality. A fundamental factor in enhancing recognition rates is to identify simple
and brief methods for establishing the presence of clinically significant cognitive
impairment at the bedside. Although both delirium and dementia involve generalised
disturbance of cognitive function, delirium can be distinguished by virtue of the
disproportionate impairment of attention and visuospatial ability. These cognitive
domains can be readily assessed in everyday clinical practice using simple bedside
tests. Both the Lighthouse and the LSD-4 provide accurate and delirium-oriented
means of  assessing cognitive function in delirium and in combination achieve a
sensitivity of over 90% for delirium detection. Their impact upon delirium detection
in everyday practice warrants further study as we seek to develop more efficient
delirium monitoring in everyday practice.
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Table 3  Accuracy of conventional bedside tests of cognition for delirium diagnosis in the overall population (n = 180) and for those with
dementia (n = 90)





Overall population (n = 180)
WORLD 89.4% (81.9–94.6) 40.8% (29.7–52.7) 67.4% (62.9-71.6) 73.8% (60.2-84.0) 68.9% (61.6-75.6)
MBT 80.8% (71.9-87.4) 71.1% (59.5-80.9) 79.3% (72.6-84.6) 73.0% (64.0-80.4) 76.7% (69.8-82.6)
SSF 75.0% (65.6-83.0) 55.3% (43.4-67.0) 69.6% (64.0-75.1) 61.8% (52.3-70.5) 66.7% (59.3-73.5)
SSB 77.9% (68.7-85.4) 57.9% (46.0-69.1) 71.7% (65.6-77.1) 65.7% (56.0-74.2) 69.4% (62.2-76.1)
Vigilance A 75.0% (65.6-83.0) 81.6% (71.0-89.6) 84.8% (77.4-90.1) 70.5% (62.7-77.2) 77.8% (71.0-83.6)
Vigilance B 94.2% (87.9-97.9) 56.6% (44.7-67.9) 74.8% (69.6-79.4) 87.8% (76.3-94.1) 78.3% (71.6-84.1)
GVS 76.9% (67.6-84.6) 63.2% (51.3-73.9) 74.1% (67.6-79.6) 66.7% (57.5-74.7) 71.1% (63.9-77.6)
CDT 72.1% (62.5-80.5) 64.5% (52.7-75.1) 73.5% (66.7-79.4) 62.8% (54.3-70.6) 68.9% (61.6-75.6)
IPT 70.2% (60.4-78.8) 73.7% (62.3-83.1) 78.5% (71.1-84.4) 64.4% (56.6-71.4) 71.7% (64.5-78.1)
Dementia population (n = 90)
WORLD 91.7% (81.6-97.2) 20.0% (7.7-38.6) 69.6% (65.4-73.6) 54.6% (28.5-78.3) 67.8% (57.1-77.3)
MBT 86.7% (75.4-94.1) 66.7% (47.2-82.7) 83.9% (75.6-89.7) 71.4% (55.6-83.3) 80.0% (70.3-87.7)
SSF 80.0% (67.7-89.2) 43.3% (25.5-62.6) 73.9% (66.8-79.8) 52.0% (36.1-67.5) 67.8% (57.1-77.3)
SSB 86.7% (75.4-94.1) 50.0% (31.3-68.7) 77.6% (70.5-83.4) 65.2% (47.3-79.7) 74.4% (64.2-83.1)
Vigilance A 83.3% (71.5-91.7) 76.7% (57.7-90.1) 87.7% (78.1-93.2) 69.7% (55.8-80.7) 81.1% (71.5-88.6)
Vigilance B 95.0% (86.1-99.0) 43.3% (25.5-62.6) 77.0% (70.9-82.2) 81.3% (57.2-93.4) 77.8% (67.8-85.9)
GVS 75.0% (62.1-85.3) 40.0% (22.7-59.4) 71.4% ( 64.3-77.6) 44.4% (30.1-59.8) 63.3% (52.5-73.3)
CDT 78.3% (65.8-87.9) 46.7% (28.3 -65.7) 74.6% (67.2-80.8) 51.9% (36.8-66.6) 67.8% (57.1-77.3)
IPT 76.7% (64.0-86.6) 60.0% (40.6-77.3) 79.3% (70.8-85.9) 56.3% (42.7-68.9) 71.1% (60.6-80.2)
MBT: Months Backward test; SSF: Spatial span forwards; SSB: Spatial span backwards; GVS: Global assessment of visuospatial abilities; CDT: Clock
Drawing test; IPT: Intersecting Pentagons test.
Table 4  Performance on Letter and Shape Drawing test and Lighthouse components (number completing correctly and %)
Overall group (n = 180) Delirium (n = 44) Comorbid delirium-dementia (n = 60) Dementia (n = 30) NNCD (n = 46)
LH-identification 60 (33) 16 (36) 11 (18) 10 (33) 24 (52)
LH-FA 83 (46) 18 (41) 14 (23) 20 (66) 31 (67)
LH-SA 64 (36) 9 (21) 7 (12) 18 (60) 30 (65)
LSD 84 (48) 17 (39) 10 (17) 19 (63) 38 (83)
NNCD: No neurocognitive diagnosis; LSD: Letter and Shape Drawing test; LH: Lighthouse.
Table 5  Accuracy of Lighthouse components and Letter and Shape Drawing test for delirium diagnosis in the overall population (n =








Overall population (n = 180)
LH-ID 74.0% (64.5-
82.1)
44.7% (33.3-6.6) 64.7% (59.2-69.8) 55.7% (45.5- 65.5) 61.7% (54.1-68.8)
LH-FA 69.2% (59.4-
77.9)
67.1% (55.4-77.5) 74.2% (67.1-80.3) 61.5% (53.4- 68.9) 68.3% (61.0-75.1)
LH-SA 84.6% (76.2-
90.9)
63.2% (51.3-73.9) 75.9% (69.8-81.0) 75.0% (64.9-82.9) 75.6% (68.6-81.6)
LSD 74.0% (64.5-
82.1)
75.0% (63.7-84.2) 80.2% (73.0-85.9) 67.9% (59.8-75.0) 74.4% (67.4-80.6)
Dementia population (n = 90)
LH-ID 81.7% (69.6-90.5) 33.3% (17.3-52.8) 71.0% (64.9-76.4) 47.6% ( 30.3-65.5) 65.6% (54.8-75.3)
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76.7% (64.0-86.6) 66.7% (47.2-82.7) 82.1% (73.1-88.6) 58.8% (45.8-70.7) 73.3% (63.0-82.1)
LH-
SA
88.3% (77.4-95.2) 60.0% (40.6-77.3) 81.5% (73.8-87.4) 72.0% (54.7-84.6) 78.9% (69.0-86.8)
LSD 83.3% (71.5-91.7) 63.3 % (43.9-80.1) 82.0% (73.7-88.1) 65.5% (50.4- 78.1) 76.7% (66.6- 84.9)
LSD: Letter and Shape Drawing test; LH: Lighthouse.
Table 6  Most accurate combinations of conventional bedside tests and the combined sustained attention of Lighthouse/Letter and
Shape Drawing Test





Overall population (n = 180)
MBT plus GVS 93.3% (86.6-97.3) 48.7% (37.0-60.4) 71.3% (66.5-75.7) 84.1% (71.4-91.8) 74.4% (67.4-80.6)
Vig A plus GVS 92.3% (85.4-96.6) 57.9% (46.0-69.1) 75.0% (69.6-79.7) 84.6% (73.3-91.7) 77.8% (71.0-83.6)
Vig A plus Vig B 93.3% (86.6-97.3) 57.9% (46.0-69.1) 75.2% (69.9-79.9) 86.3% (75.0-93.0) 78.3% (71.6-84.1)
MBT plus Vig A 90.4% (83.0-95.3) 61.8 % (50.0-72.8) 76.4% (70.7-81.3) 82.5% (71.8- 89.7) 78.3% (71.6- 84.1)
LSD-4 plus
Lighthouse-SA
91.4% (84.2-96.0) 51.3 % (39.6-63.0) 72.0 % (66.9-76.5) 81.3% (69.1-89.4) 74.4% (67.4-80.6)
Dementia population (n = 90)
MBT plus GVS 93.3% (83.8-98.1) 30.0% (14.7-49.4) 72.7% (67.6-77.3) 69.2% 43.0-87.0) 72.2% (61.8-81.2)
Vig A plus GVS 95.0% (86.1-98.9) 33.3% (17.3- 52.8) 74.0% (68.7- 78.7) 76.9% (49.8-91.8) 74.4% (64.2- 83.1)
Vig A plus Vig B 95.0% (86.1-98.9) 43.3% (25.5-62.6) 77.0% (70.9-82.2) 81.3 (57.2-93.4) 77.8% (67.8-85.9)
MBT plus Vig A 95.0% (86.1-98.9) 50.0% (31.3-68.7) 79.2% (72.6-84.5) 83.3% (61.1-94.1) 80.0% (70.3-87.7)
LSD-4 plus LH-SA 95.0% (86.1-99.0) 43.3% (25.5-62.6) 77.0% (70.9-82.2) 81.3% (57.2-93.4) 77.8% (67.8-85.9)
MBT: Months Backward test; GVS: Global assessment of visuospatial abilities; CDT: Clock Drawing test; IPT: Intersecting Pentagons test; LH: Lighthouse;
LSD: Letter and Shape Drawing test.
Figure 3
Figure 3  Receiver operating characteristic analyses depicting the accuracy of conventional bedside tests of cognition for delirium diagnosis in the overall
population (n = 180). ROC: Receiver operating characteristic analyses.
ARTICLE HIGHLIGHTS
Research background
Efficient detection of delirium and comorbid delirium-dementia is a key diagnostic challenge.
It’s  a  key challenge of  developing of  new, efficient  delirium-focused methods of  cognitive
assessment for improved detection of neurocognitive disorders in everyday clinical practice.
Research motivation
This study the accuracy of a series of commonly used conventional tests as well as these novel
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tests in the detection of delirium in a real world sample of older hospital medical patients.
Research objectives
The authors aimed to compare the accuracy of two novel bedside tests of attention, vigilance and
visuospatial function with conventional bedside cognitive tests in identifying delirium in older
hospitalized patients.
Research methods
This cognitive performance study was conducted in referrals to a consultation-liaison psychiatry
service of patients with delirium, dementia, comorbid delirium-dementia, as well as comparison
subjects  with  no  neurocognitive  diagnosis.  Altered  mental  state  consecutive  cases  were
identified on daily rounds.
Research results
All conventional tests had sensitivity of > 70% for delirium, with best overall accuracy for the
Vigilance-B, Vigilance-A and Months Backward tests. The sustained attention component of the
Lighthouse Test was the most distinguishing of delirium.
Research conclusions
Vigilance and visuospatial ability can help to distinguish neurocognitive disorders, including
delirium, from other presentations. The Lighthouse test, Letter and Shape Drawing test are novel
tests with high accuracy for detecting delirium.
Research perspectives
Lighthouse test, Letter and Shape Drawing tests’ impact upon delirium detection in everyday
practice warrants further study.
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